These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model. Brownell AL; Canales K; Chen YI; Jenkins BG; Owen C; Livni E; Yu M; Cicchetti F; Sanchez-Pernaute R; Isacson O Neuroimage; 2003 Oct; 20(2):1064-75. PubMed ID: 14568476 [TBL] [Abstract][Full Text] [Related]
3. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism. Otsuka M; Ichiya Y; Hosokawa S; Kuwabara Y; Tahara T; Fukumura T; Kato M; Masuda K; Goto I J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644 [TBL] [Abstract][Full Text] [Related]
4. Drug development for neurodegenerative diseases: role of PET. Rinne JO Ann Med; 1999 Dec; 31(6):444-9. PubMed ID: 10680860 [TBL] [Abstract][Full Text] [Related]
5. The cognitive neuropsychology of Parkinson's disease: a functional neuroimaging perspective. Owen AM; Doyon J Adv Neurol; 1999; 80():49-56. PubMed ID: 10410702 [No Abstract] [Full Text] [Related]
6. Thirty years of dopamine research. Carlsson A Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570 [No Abstract] [Full Text] [Related]
7. Cerebral blood flow and oxygen metabolism measurement with positron emission tomography in Parkinson's disease. Leenders KL; Wolfson L; Jones T Monogr Neural Sci; 1984; 11():180-6. PubMed ID: 6610825 [No Abstract] [Full Text] [Related]
8. Is it Parkinson's disease? Hely M Aust Fam Physician; 1992 Oct; 21(10):1411-6. PubMed ID: 1444967 [TBL] [Abstract][Full Text] [Related]